Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.
Phase of Trial: Phase IV
Latest Information Update: 06 Nov 2015
At a glance
- Drugs Aclidinium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms A NEED
- Sponsors Almirall S.A.
- 06 Nov 2015 New trial record